Introduction: Paraquat (PQ) is a widely used herbicide with a high mortality rate when ingested. The aim of the present study was to assess the effectiveness of repeated cyclosphosphamide (CP) and methylprednisolone (MP) combination in the treatment of PQ poisoning. Design: Randomised, double-blinded, placebo-controlled trial. Methods: Eligible participants were 47 patients with moderate to severe PQ poisoning within 24 hours of hospitalisation. Patients were allocated in a random fashion, 24 as the intervention and 23 as the control group. All patients received two cycles of eight hours of haemoperfusion with charcoal, and underwent emergency haemodialysis. After the dialysis, the intervention group received 15 mg/kg CP for two days and 1g MP for three days. The control group received routine supportive care. Outcome parameters, including mortality, incidence of hypoxia, hepatitis and renal failure were compared between the two groups. Results: There were no significant differences between the two groups with regard to age, sex, baseline liver function test, creatinine, time from poisoning to dialysis, and time from poisoning to the hospitalisation. Although the incidence of hepatitis and acute renal failure did not differ significantly between the two groups, the incidence of hypoxia and mortality rate was lower in the intervention group. The number need-to-treat to reduce one mortality was 2.8. Conclusion: The results suggest that CP and MP repeated treatment can reduce the mortality rate in moderate to severe PQ intoxication. (Hong Kong j.emerg.med. 2015;22:235-240 
Introduction
Paraquat (PQ) is a widely used herbicide with high mortality when ingested. Most cases of PQ poisoning result from intentional or suicidal ingestion. PQ poisoning causes death in 50-90% of the cases, and PQ related mortality increases to near 100% when consumed intentionally. 1 Hong Kong local study by Wong et al reported a mortality rate of around 57%. 2 Generally the severity was classified as mild, moderate, and severe. The mild form is accompanied by oral irritation and gastric upset and completely recoverable. In moderate to severe poisoning, acute liver failure and pulmonary fibrosis lead to death within two to three weeks. Acute fulminant poisoning followed by multi-organ failure and cardiovascular collapse leads to death of the patient within one week. 3 Retrospective studies have identified that urine and plasma concentration of PQ during the first 24 hours of intoxication may help in patient's outcome prediction. 4 Urine test of PQ is a quick and convenient way for quantitative and semi-quantitative assessment of the severity and intensity of poisoning in the emergency department. 5 The results of the review of the various treatment methods of PQ poisoning, including prophylactic absorbents, pharmacological assessment, radiotherapy, 6 haemodialysis and haemoperfusion 7 were disappointing. Although a number of studies suggested that high doses of cyclophosphamide and dexamethasone therapy, had 75% survival, 8 but others did not specify the usefulness of these findings. 9 Thus, efficacy of high-dose cyclophosphamide and dexamethasone therapy remains controversial.
High-dose cyclophosphamide and methylprednisolone pulse therapy, in patients with severe pulmonary damage from systemic lupus erythematous and Wegener's granulomatosis 10, 11 has been used with higher efficacy, and lower side effects than high-dose cyclophosphamide and dexamethasone. One report 12 indicated that cyclophosphamide and methylprednisolone pulse therapy might be effective in the treatment of the moderate to severe PQ poisoning.
The aim of the current study was to examine the impact on mortality rate of pulse therapy with methylprednisolone and cyclophosphamide in patients with moderate to severe PQ poisoning.
Methods

Study design and population
This randomised, double-blind, placebo-controlled trial was conducted in Razi Hospital, Ahvaz, Iran during the years 2010 to 2012. This study was approved by Ahvaz Jundishapur University of Medical Sciences Ethics Committee. It was also registered in Iranian Registration of Clinical Trial (IRCT2014012611873N2).
Patient inclusion
All patients with history of exposure to paraquat concentration in urine or plasma, who arrived at our hospital within one week of paraquat ingestion, with a navy blue or dark blue color in urine dithionite tests, were classified as having PQ intoxication and were included in this study. Patients with colorless urine dithionite tests, who had not orally ingested PQ, who were younger than 15 years or older than 45 years were excluded. Moderate to severe poisoning to PQ was defined by the color in the urine dithionite tests as navy blue or dark blue. Urine dithionite test was a commonly adopted point-of-care tests for the documentation of PQ exposure which is semi-quantitative. A navy blue or dark blue color would indicate a concentration of more than 0.1 mg/L. Serum PQ levels was unavailable in the study centre. For patients with mild or no documented exposure of paraquat poisoning in urine tests (colourless or light blue), they were excluded from the study.
Randomisation and allocation concealment
At the time of admission, demographic characteristics and the time between PQ intake and the entrance to the emergency department were recorded. Then patients were allocated randomly into two groups (intervention and control) in a 1:1 ratio using a computer program. The investigator was provided with a sealed envelope containing a code number for each group.
Clinical assessments and treatments
Considering the complications of PQ poisoning, venous blood samples were taken from all participants and serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, and creatinine levels were measured through at baseline and were repeated serially. Afterwards, all patients received conventional standard poisoning care with activated charcoal (1 g/kg in water; maximum dose 50 g) was given as soon as possible per oral or via a nasogastric tube to patients who present within approximately two hours of ingestion. Gastric lavage is contraindicated due to paraquat-induced caustic injury. However, in cases that present early, a nasogastric tube was inserted and the stomach contents aspirated prior to administration of charcoal. Lavage was performed adequately with tap water or normal saline in adults. We introduce small aliquots of lavage solution (200 to 300 mL) into the stomach and then remove them. We noticed that the amount of fluid that is returned should approximate the amount introduced. We continue lavage until the fluid becomes clear. Based on our protocol, two episodes of eight-hour charcoal haemoperfusion were performed for all subjects with a 4-hour interval. Haemodialysis was also arranged for renal replacement if necessary. For arrangement of double blindness setting, we prepared calculated cyclophosphamide i n 2 0 0 m l d e x t r o s e s a l i n e 5 % , c a l c u l a t e d methylprednisolone in 200 ml dextrose saline 5% and placebo (only 200 ml dextrose saline 5%) in similar and unknown sets which neither patient nor nurse/ physician could not differentiate between them. After dialysis, the intervention group underwent pulse therapy, i.e. 15 mg/kg cyclophosphamide in 200 ml dextrose saline 5% and 1 g methylprednisolone in 200 ml dextrose saline 5% were intravenously infused for two hours per day. The two medications were prescribed with short intervals. The treatment with cyclophosphamide continued for two consecutive days and the treatment with methylprednisolone repeated for three consecutive days. Control group only received routine supportive care and placebo. Throughout the hospitalisation, daily examinations were conducted to assess systemic, hepatic, and renal complications and the side effects of medicines including cyclophosphamideinduced thrombocytopenia 13 and methylprednisoloneinduced leukocytosis. 14 In order to do so, daily arterial and venous blood samples were obtained to analyse blood gases and measure blood cell count, creatinine, ALT, AST, and bilir ubin levels, respectively. Chest radiography was also used to assess possible respiratory complications.
Outcome measures
The primary outcome was mortality within three days. The secondary outcomes were hepatic complications, renal failure (serum creatinine higher than 1.4 mg/dl) Hepatitis was defined as ALT and AST greater than 70 U/l or total bilirubin more than 3 mg/dl.
Statistical methods
Quantitative variables were compared with Student's t-tests. Chi-square tests were also applied to compare the two groups in terms of qualitative variables and outcomes. Relative risks and their 95% confidence intervals were calculated. The number-need-to-treat was calculated for mortality. All statistical analyses were conducted with SPSS for Windows 20.0 (IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp). All statistical inferences adopt a significance level of 5%.
Results
Th is c linical tria l evalua ted 47 P Q-po ison ed individuals in two groups of intervention (n=24) and control (n=23). There were no significant differences between two groups on age, gender, baseline AST, ALT, bilirubin and creatinine. Besides, time from poisoning to hospitalisation and time from poisoning to dialysis were comparable between two groups (Table1).
O ver a ll, 20 (4 2 . 6%) a n d 2 6 (5 5 .3 %) o f th e participants developed hepatitis and renal failure, respectively. A total of 18 subjects (38.3%) suffered from both complications. The frequency of patients with both hepatitis and renal failure was significantly lower in the intervention group than in the control group [29.2% (n=7) vs. 47.8% (n=11); p=0.188].
Of the 20 cases who died, 16 subjects (88.9%) including five from the intervention group and 11 from the control group had both hepatitis and renal failure. The mean time from poisoning to death was 8.64.6 hours. Table 2 compared the two groups in terms of frequency of the studied outcomes and changes in laboratory indices. The mortality rate was significantly lower in the treatment group (25%) compared to the control group (60.9%) (p=0.013). The number-needto-treat to reduce one death was 2.8. Likewise, AST showed significantly higher changes in the intervention group. For the secondary outcomes, while pulse therapy had no significant effects on the incidence of hepatitis and renal failure, it had a preventive effect on the incidence of death. Moreover, hypoxia was significantly lower in the intervention group (RR=0.564, p=0.025). 18 indicated a mortality rate as 81.6% and 54%, respectively. In 1982, a review of 28 studies revealed the rates to vary between 33% and 78%. 19 Apparently, the mortality rate in the control group of the current study was higher than the values reported by a number of previous studies. The reason might relate to the long interval (10 hours on average) between poisoning and referring to the hospital.
Previous studies have reported different ranges for the frequency of renal failure following PQ poisoning. While Kim et al found the complication in 34.7% of the patients, 20 another study in China suggested 73.0% of PQ-poisoned individuals to develop acute kidney injury. 21 We found kidney failure in 55.3% of all par ticipants. Furthermore, despite the higher frequency of the complication in the control group, the difference between the two groups was not statistically significant. In recent years, restrictions on the use of PQ have decreased the frequency of PQ poisoning in developed countries. However, the problem is still quite prevalent in areas where PQ i s e m p l o y e d f o r a g r i c u l t u r a l p u r p o s e s . 2 2 Complications of PQ poisoning depend widely on the dose and type of exposed, as well as severity of po is on in g an d ma y va r y f ro m th e ab senc e of complications in mild cases to death in 100% of severe cases. While the exact mechanism of PQ toxicity is not clear, this herbicide seems to induce mucosal side effects in various organs by releasing free oxygen radicals (superoxide and hydrogen peroxide) near mucous membranes. 23 The conventional treatments for PQ poisoning, i.e. using adsorbents, supportive therapy, haemodialysis, and haemoperfusion, are not effective in moderate to severe cases. 12 Hence, finding a novel, strong anti-inflammatory treatments is a major concern for researchers in this field. Pulse therapy is recently proposed to reduce the inflammation caused by PQ poisoning. Addo and Poon-King were among the first scientists who assessed the efficacy of high-dose corticosteroids and reported a 75% improvement in survival. 8 Lin et al used high-dose cyclophosphamide and methylprednisolone in pulse therapy and found a significant mortality reduction in the intervention group despite the absence of any significant differences between the inter vention a n d c o n t r o l g r o u p s regarding baseline characteristics and inter val b et we en p o is o n in g a n d h o s p i t a l is a t io n . 12 In Hamadan (Iran), Afzali et al studied 45 PQ-poisoned p a t i e n t s a m o n g w h o m 2 0 h a d m o d e r a t e t o severe poisoning. Of these 20 subjects, 11 were treated with standard suppor tive therapy and nine received the conventional treatment accompanied by 15 mg/kg cyclophosphamide for two days, 1 g methylprednisolone for three days, and mesna for four days. The mortality rate was 81.8% in the control group and 33.3% in the pulse therapy group. Moreover, the two groups had a significant difference in the incidence of death. 24 In another study, Lin et al administered repeated pulse therapy and observed significantly lower mortality in the pulse therapy group compared to the control group. 25 Similarly, Ghaffari et al indicated that cyclophosphamide and methylprednisolone could significantly decrease mortality related to pulmonary fibrosis. 26 Previous studies suggested that severe inflammation and fibrosis of lung might cause hypoxia and play a role in increasing mortality in PQ poisoning. 12, 24 Our results supported this hypotheseis.
Limitations
For this current study, serum PQ was not measured. The determination on the severity of poisoning was based on qualitative urine tests. We were unable to discriminate between moderate and severe cases of poisoning. Secondly, we only evaluated death in a three-day period, thus longer follow-up for at least one month could reveal more useful findings.
Conclusions
Our findings suggest that cyclophosphamide and methylprednisolone pulse therapy can reduce hypoxia and mortality rate in moderate to severe PQ poisoning patients.
